SCHEMBL4924013

SCHEMBL4924013

COc1ccc(Cl)cc1C1=C(OS(=O)(=O)C(F)(F)F)CCCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
HPGD P15428 3/20 0.41
KDM4E B2RXH2 3/20 0.39
RAB9A P51151 2/20 0.39
POLB P06746 1/20 0.39
PTGS2 P35354 2/20 0.36
TRPV4 Q9HBA0 1/20 0.36
PTGS1 P23219 1/20 0.36
HTT P42858 1/20 0.36
NR1I2 O75469 4/20 0.35
ERN1 O75460 1/20 0.34
SLC9A1 P19634 1/20 0.34
NR3C1 P04150 1/20 0.34
PGR P06401 1/20 0.34
CHRM1 P11229 1/20 0.34
DRD2 P14416 1/20 0.34
DRD4 P21917 1/20 0.34
DRD3 P35462 1/20 0.34
CYP2C9 P11712 1/20 0.34
PTGER1 P34995 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5696523 0.91 TRPV4 (0.39) ALDH1A1HPGDKDM4ERAB9APOLB
SCHEMBL6569016 0.75 CYP2A6 (0.33) ALDH1A1POLBPTGS2PTGS1PGR
SCHEMBL8914993 0.74 PTGS2 (0.48) PTGS2PTGS1
SCHEMBL6068893 0.71 HDAC4 (0.42) ALDH1A1KDM4EPTGS2PGRDRD2
SCHEMBL17254341 0.70 ERN1 (0.48) ALDH1A1HPGDKDM4ERAB9APOLB
SCHEMBL7363820 0.70 PDE4A (0.50)
SCHEMBL2752719 0.70 DRD2 (0.31) DRD2DRD4DRD3
SCHEMBL4160550 0.69 PTGS2 (0.41) PTGS2PTGS1DRD2DRD4DRD3
SCHEMBL4158464 0.68 SMN1; SMN2 (0.43) ALDH1A1HPGDKDM4ERAB9APOLB
SCHEMBL4924977 0.68 ALDH1A1 (0.44) ALDH1A1HPGDKDM4ERAB9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080234335-A1 Cyclohexene Compounds GLAXO GROUP LIMITED (GB) 2008-09-25 US disclosed
EP-1670764-A1 CYCLOHEXENE COMPOUNDS GLAXO GROUP LIMITED (GB) 2006-06-21 EP disclosed
WO-2005037794-A1 CYCLOHEXENE COMPOUNDS GLAXO GROUP LIMITED (GB) 2005-04-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080234335-A1 Cyclohexene Compounds C1R, CYP1B1, CYP2C9 ALDH1A1 2527/4885HPGD 2218/4885KDM4E 1090/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.